Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Shimadzu UK Grows Sales Orders by 30%!

Published: Tuesday, May 07, 2013
Last Updated: Tuesday, May 07, 2013
Bookmark and Share
Company has achieved sales order growth across many products in the Shimadzu range.

Despite challenging economic conditions and in the face of fierce competition, Shimadzu UK has achieved sales order growth of 30% in the last two years.

This growth has been achieved across many products in the formidable Shimadzu range including GC, GCMS, LC, LCMS, Spectroscopy, TOC and Material Testing Solutions.

A long-established company, Shimadzu is a global presence in mass spectrometry, chromatography, atomic spectroscopy and thermal analysis, and is known for its high quality engineering and robust, technically advanced scientific instrumentation.

Darin Enefer, Shimadzu UK’s Sales & Marketing Director, believes that the company is now really making its mark in the highly competitive UK market. “We have a committed and extremely knowledgeable team of people in Shimadzu UK who ensure that our customers get the highest levels of support and continuity of service, as well as state-of-the-art analytical solutions. Our reputation is growing in the best possible way, through having satisfied customers who pass on that confidence to others.”

Having undertaken a survey of laboratory personnel and those in purchasing roles, Shimadzu UK identified three areas of opportunity on which to build, and which Darin Enefer believes are proving crucial to the company’s current success. “It seemed that a gap existed in the market for a scientific instrumentation provider to do three things: Listen; Provide insight; Focus on relationships,” he said.

“In our view taking the time to listen and fully understand what a customer wants is absolutely essential. We recruit and retain people who are both scientifically competent and possess the interpersonal skills needed to build lasting, trust-based relationships’’.

“When it comes to ‘providing insight’, we focus intensively on becoming a ‘technical ally’ for the customer, co-creating solutions that really help them towards more effective ways to implement method development and obtain the most accurate and definitive analysis. Many companies in tough economic times cut back on staff. We did the opposite and have in fact recruited more and more technical specialists who work with the customer, helping them achieve their objectives. I believe it is more risky to cut back than invest. We decided to invest because we knew that once the customer tried the Shimadzu solution, they would be wowed by its accuracy, design, robustness and reliability. Knowing this gave us the confidence to invest in more people.”

“Many customers today rely on us as the ‘provider of choice’, supporting their professional reputation through delivering results that they can absolutely depend on.”

“And finally, our ‘Focus on the relationship,” means that we don’t stop at the sale, but always look to the longer term, working as a team with our customers and supporting them in mapping their short, medium and long term requirements. Our team approach means that customers often build relationships with sales, service, management and operational staff, all of whom are UK based and readily available. An ‘implementation manager’ assigned to every installation makes sure the customer is fully informed so that the installation itself is successful, training is delivered effectively and the user can quickly apply the solution they have bought to maximize the return on their investment.”

The rapidly growing customer base is testament to Shimadzu UK’s commitment to delivering class leading support in all areas.

Summing up, Darin Enefer said, “We are proud of our company, our people and most importantly how we work. It’s about principles and pride and making sure we deliver on our promises.”

‘’Many customers have commented that they are pleased they took the time to take a look at what we had to offer when making their decisions on which equipment to buy and which company to choose, and more and more of them are choosing us’’.

‘’We are absolutely a sales organization achieving its sales objectives but we do it by helping customers exceed theirs. I have been in business for over 25 years and believe that you cannot go too far wrong if you simply try and help the customer!’’


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More Than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Shimadzu Wins R&D 100 Award for Nexera Unified Chromatography System
The Nexera UC system is the world’s first ever unified and fully automated system that combines supercritical fluidic extraction (SFE) with supercritical fluid chromatography (SFC).
Tuesday, November 24, 2015
Agilent, Shimadzu Release GC Instrument Control for CDS
The instrument control provides customers more freedom of choice when selecting a chromatography data system.
Wednesday, August 27, 2014
Shimadzu, Indigo BioSystems Announce Partnership
The companies will leverage the power of ASCENT™ clinical solutions on ultra-fast mass spectrometry platforms.
Monday, June 16, 2014
Shimadzu Corporation, MacCoss Lab of Biological Mass Spectrometry, UW Collaborate
The companies will leverage the power of ASCENT™ clinical solutions on ultra-fast mass spectrometry platforms.
Monday, June 16, 2014
Shimadzu Registers HPLC and LCMS Instruments as Class I Medical Devices with FDA
Products are the first Shimadzu analytical instruments registered with the FDA as medical devices.
Tuesday, April 01, 2014
Shimadzu Establishes Latin American Subsidiary
Uruguayan subsidiary will strengthen company's sales and distribution whilst providing better support for customers and distributors in Central and South America.
Tuesday, November 12, 2013
Shimadzu Achieves ISO 13485 Certification for US LC-MS Facility
ISO 13485 is the globally recognized international quality management standard for medical equipment.
Wednesday, September 25, 2013
Shimadzu UK Appoints Product Specialist for AA
Company strengthens focus on molecular and atomic spectroscopy with new specialist recruit.
Thursday, July 19, 2012
Shimadzu and The University of Texas Form Shimadzu Center for Advanced Analytical Chemistry
Located in the university’s Chemistry & Physics Building, the center contains $6 million of chromatography, mass spectrometry and spectroscopy equipment, which is the largest installation of Shimadzu analytical instrumentation in the Western Hemisphere.
Tuesday, April 10, 2012
Shimadzu Corporation Names New Director and President of Shimadzu Scientific Instruments
Shuzo Maruyama has been named president of Shimadzu Scientific Instruments (SSI)
Monday, March 12, 2012
Spectroscopy Veteran Joins Shimadzu UK to Drive UK Sales Forward
Dr Robert Keighley has appointed as new spectroscopy and TOC business manager.
Friday, September 16, 2011
Shimadzu UK Opens Evaluation Laboratory Centre to Promote Excellence in Analytical Instrumentation
New 1500m² world-class product evaluation laboratory facility at UK headquarters in Buckinghamshire.
Wednesday, July 13, 2011
Multivariate Data Analysis Solutions for FTIR Spectrophotometry
Shimadzu Scientific Instruments and CAMO Software have announced a partnership that will enable Shimadzu to expand its capabilities for FTIR spectrophotometry. Shimadzu will now provide CAMO Software’s multivariate data analysis (MVDA) software, The Unscrambler® to FTIR customers requiring chemometric analysis.
Friday, November 05, 2010
Shimadzu, Ceres Nanosciences and Nonlinear Dynamics Introduce Nanotrap™ Biomarker Discovery Platform
Shimadzu Scientific Instruments has partnered with Ceres Nanosciences and Nonlinear Dynamics to bring the future of biomarker discovery to laboratory researchers.
Tuesday, March 16, 2010
Shimadzu and Phenomenome Discoveries Announce Exclusive Collaboration
Shimadzu and PDI will develop software tools for global profiling using high mass accuracy MSn data.
Monday, July 02, 2007
Scientific News
Head Injury Patients have Protein Clumps Associated with Alzheimer’s Disease
Scientists have revealed that protein clumps associated with Alzheimer's disease are also found in the brains of people who have had a head injury.
Exposure to Air Pollution 30 Years Ago Associated with Increased Risk of Death
Exposure to air pollution more than 30 years ago may still affect an individual's mortality risk today, according to new research from Imperial College London.
More Then 1 in 20 U.S. Children have Dizziness and Balance Problems
Researchers at NIH have found that girls have a higher prevalence of dizziness and balance problems compared to boys, 5.7 percent and 5.0 percent.
Biosensors on Demand
New strategy results in custom "designer proteins" for sensing a variety of molecules.
Low-Cost, Portable NQR Spectroscopy
A researcher at Case Western Reserve University is developing a low-cost, portable prototype designed to detect tainted medicines and food supplements that otherwise can make their way to consumers. The technology can authenticate good medicines and supplements.
Structure of Brain Plaques in Huntington's
Researchers at the University of Pittsburgh School of Medicine have shown that the core of the protein clumps found in the brains of people with Huntington's disease have a distinctive structure, a finding that could shed light on the molecular mechanisms underlying the neurodegenerative disorder.
Insights into the Function of the Main Class of Drug Targets
About thirty percent of all medical drugs such as beta-blockers or antidepressants interact with certain types of cell surface proteins called G protein coupled receptors.
Spero Therapeutics Announces $30 Million Series B Preferred Financing
Company has announced financing of $30 million to support development of novel therapies to treat gram-negative bacterial infections.
Unique Mechanism for a High-Risk Leukemia
Researchers uncovered the aberrant mechanism underlying a notoriously treatment-resistant acute lymphoblastic leukemia subtype; findings offer lessons for understanding all cancers.
Visualizing a Cancer Drug Target at Atomic Resolution
Using cryo-electron microscopy, researchers were able to view, in atomic detail, the binding of a potential small molecule drug to a key protein in cancer cells.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!